AKT1 and non-small cell lung carcinoma: Moreover, it has been shown that through the reduced activity of Nrf2 and inhibition of the PI3K/Akt/GSK-3 pathway, the simultaneous administration of DT and paclitaxel effectively caused cell death in non-small cell lung cancer cells41.